Filing Details

Accession Number:
0001723128-19-000116
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-07 16:32:08
Reporting Period:
2019-08-07
Accepted Time:
2019-08-07 16:32:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1723128 Amneal Pharmaceuticals Inc. AMRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239546 S Andrew Boyer C/O Amneal Pharmaceuticals, Inc.
400 Crossing Boulevard, 3Rd Floor
Bridgewater NJ 08807
Exec Vp, Comm Optns No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-08-07 66,666 $2.89 95,968 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.86 per share to $2.92 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.